ALLISON SYLVESTER: Open Payments
NPI 1689178535 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $164 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $170 |
| Gilead Sciences, Inc. | 1 | $139 |
| Hologic Sales and Service, LLC | 1 | $129 |
| Edwards Lifesciences Corporation | 1 | $128 |
| Viatris Specialty LLC | 1 | $125 |
Products named: Yeztugo, APTIMA, SAPIEN 3 Ultra RESILIA, YUPELRI.
Industry payments across MA — which companies pay providers there.
